PCM
Peregrine Capital Management Portfolio holdings
AUM
$3.32B
1-Year Return
23.17%
This Quarter Return
+9.97%
1 Year Return
+23.17%
3 Year Return
+97.35%
5 Year Return
+164.6%
10 Year Return
–
AUM
$3.68B
AUM Growth
+$211M
(+6.1%)
Cap. Flow
-$41.6M
Cap. Flow
% of AUM
-1.13%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
337
New
20
Increased
84
Reduced
184
Closed
17
Top Buys
| 1 |
MYR Group
MYRG
|
$11M |
| 2 |
Montrose Environmental
MEG
|
$10.3M |
| 3 |
LTHM
Livent Corporation
LTHM
|
$10.2M |
| 4 |
Uber
UBER
|
$10.1M |
| 5 |
Titan Machinery
TITN
|
$9.6M |
Top Sells
| 1 |
AMN Healthcare
AMN
|
$15.2M |
| 2 |
MDC
M.D.C. Holdings, Inc.
MDC
|
$13.8M |
| 3 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
$10.3M |
| 4 |
Atlantic Union Bankshares
AUB
|
$10M |
| 5 |
Taylor Morrison
TMHC
|
$9.92M |
Sector Composition
| 1 | Technology | 23.51% |
| 2 | Healthcare | 18% |
| 3 | Financials | 14% |
| 4 | Consumer Discretionary | 12.52% |
| 5 | Industrials | 12.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Encore Capital Group
ECPG
$1.02B
| $6.36M | 0.17% |
130,858
-5,409
| -4% | -$263K |
|
227
BrightView Holdings
BV
$1.36B
| $6.33M | 0.17% |
881,355
-36,417
| -4% | -$261K |
|
228
PAR Technology
PAR
$1.96B
| $6.31M | 0.17% |
191,559
+890
| +0.5% | +$29.3K |
|
229
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $6.14M | 0.17% |
1,437,553
+370,369
| +35% | +$1.58M |
|
230
Ionis Pharmaceuticals
IONS
$9.76B
| $6.12M | 0.17% |
149,198
-49
| -0% | -$2.01K |
|
231
Virtu Financial
VIRT
$3.29B
| $6.09M | 0.17% |
356,157
-62
| -0% | -$1.06K |
|
232
Cytokinetics
CYTK
$6.34B
| $5.9M | 0.16% |
180,728
-18,688
| -9% | -$610K |
|
233
Stoneridge
SRI
$226M
| $5.89M | 0.16% |
312,640
-12,895
| -4% | -$243K |
|
|
CDMO
234
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $5.7M | 0.16% |
408,086
-140
| -0% | -$1.96K |
|
235
Azenta
AZTA
$1.39B
| $5.57M | 0.15% |
119,396
-43
| -0% | -$2.01K |
|
236
Victoria's Secret
VSCO
$2.1B
| $5.23M | 0.14% |
300,188
-12,396
| -4% | -$216K |
|
237
RB Global
RBA
$21.4B
| $5.12M | 0.14% |
85,397
-51
| -0.1% | -$3.06K |
|
238
Synaptics
SYNA
$2.7B
| $5.06M | 0.14% |
59,308
-18
| -0% | -$1.54K |
|
239
Digital Turbine
APPS
$483M
| $4.94M | 0.13% |
532,819
+96,204
| +22% | +$893K |
|
240
Syndax Pharmaceuticals
SNDX
$1.47B
| $4.89M | 0.13% |
+233,738
| New | +$4.89M |
|
241
Monro
MNRO
$530M
| $4.7M | 0.13% |
115,793
-37
| -0% | -$1.5K |
|
242
Tandem Diabetes Care
TNDM
$850M
| $4.67M | 0.13% |
190,458
-58
| -0% | -$1.42K |
|
243
Sarepta Therapeutics
SRPT
$1.96B
| $4.58M | 0.12% |
40,012
-30,565
| -43% | -$3.5M |
|
|
SWTX
244
DELISTED
SpringWorks Therapeutics
SWTX
| $4.44M | 0.12% |
169,493
-50
| -0% | -$1.31K |
|
|
LUCK
245
Lucky Strike Entertainment Corporation
LUCK
$1.4B
| $3.94M | 0.11% |
+338,165
| New | +$3.94M |
|
246
Ventyx Biosciences
VTYX
$180M
| $3.3M | 0.09% |
+100,485
| New | +$3.3M |
|
247
Adaptive Biotechnologies
ADPT
$1.96B
| $3.14M | 0.09% |
467,286
-109
| -0% | -$731 |
|
248
Manhattan Associates
MANH
$13B
| $2.04M | 0.06% |
10,214
+404
| +4% | +$80.8K |
|
249
Novanta
NOVT
$4.18B
| $1.69M | 0.05% |
9,202
+1,519
| +20% | +$280K |
|
250
MasTec
MTZ
$14B
| $1.66M | 0.05% |
14,105
+2,417
| +21% | +$285K |
|